Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Editorial [Hot Topic:Epigenetic Mechanisms and Therapeutic Strategies (Guest Editors: Victoria Samanidou and Leda Kovatsi)] promotion: free to download

Volume:18   Issue:12
Pp: 1732-1732
Victoria Samanidou and Leda Kovatsi
DOI: 10.2174/092986711795496854

Epigenetic Mechanisms and Kidney Diseases

Volume:18   Issue:12
Pp: 1733-1739
V. Liakopoulos, P. I. Georgianos, T. Eleftheriadis and P. A. Sarafidis
DOI: 10.2174/092986711795496827

Epigenetic Mechanisms in Alzheimer's Disease

Volume:18   Issue:12
Pp: 1751-1756
M. Daniilidou, M. Koutroumani and M. Tsolaki
DOI: 10.2174/092986711795496872

Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction

Volume:18   Issue:12
Pp: 1765-1774
L. Kovatsi, D. Fragou, V. Samanidou, S. Njau and S. Kouidou
DOI: 10.2174/092986711795496836

Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment

Volume:18   Issue:12
Pp: 1775-1784
L. De Santi, G. Polimeni, S. Cuzzocrea, E. Esposito, E. Sessa, P. Annunziata and P. Bramanti
DOI: 10.2174/092986711795496881

It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine

Volume:18   Issue:12
Pp: 1785-1805
D. Gabriel, M. F. Zuluaga, H. van den Bergh, R. Gurny and N. Lange
DOI: 10.2174/092986711795496782

Cardiovascular Complications in Diabetes: Lessons from Animal Models

Volume:18   Issue:12
Pp: 1806-1819
M. A. Potenza, C. Nacci, S. Gagliardi and M. Montagnani
DOI: 10.2174/092986711795496755

NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

Volume:18   Issue:12
Pp: 1820-1831
M. Munoz and R. Covenas
DOI: 10.2174/092986711795496746

Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update

Volume:18   Issue:12
Pp: 1832-1845
A. Napolitano, P. Manini and M. d'Ischia
DOI: 10.2174/092986711795496863

Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention

Volume:18   Issue:12
Pp: 1846-1860
P. Palozza, N. Parrone, R. Simone and A. Catalano
DOI: 10.2174/092986711795496845

Claudin as a Target for Drug Development

Volume:18   Issue:12
Pp: 1861-1865
A. Takahashi, M. Kondoh, H. Suzuki and K. Yagi
DOI: 10.2174/092986711795496809